Lung Texture Analysis

Imbio

Lung Texture Analysis ™ from Imbio automatically applies computer vision to transform a standard chest CT into a map of the lung textures to identify ILD’s and other fibrotic conditions (normal, ground glass, reticular, honeycomb and hyperlucent). LTA’s DICOM image series provides a texture overlay on the patient scan to highlight abnormalities and increase diagnostic confidence. LTA’s physician summary report provides quantification of the textures by lung region.

Information source: Vendor
Last updated: February 25, 2024

General Information

General
Product name	Lung Texture Analysis
Company	Imbio
Subspeciality	Chest
Modality	CT
Disease targeted	Interstitial lung diseases, fibrosis, UIP
Key-features	Fibrotic condition identification, percentage of lung affected, volume quantification, report generation
Suggested use	Before: stratifying reading process (non, single, double read), adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand) Without interference of a radiologist: AI-only diagnosis

Technical Specifications

Data characteristics
Population	All chest CT's, lung cancer screening population, COPD, emphysema, ILD, Covid-19
Input	Low dose or HRCT
Input format	DICOM
Output	Report in PDF or DICOM, overlays, lobe segmentation overlay
Output format	DICOM, HL7, PDF
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment	Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDD
FDA	No or not yet
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	2015
Distribution channels	Nuance PIN, Eureka Clinical AI, syngo.via, Wellbeing Software, Aidoc aiOS, Blackford
Countries present (clinical, non-research use)	>10
Paying clinical customers (institutes)	>20
Research/test users (institutes)	>20
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers	NICE Medtech innovation briefing: Lung texture analysis for measuring interstitial lung diseases (read)